Arbutus Biopharma Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABUS Nasdaq 8731 http://www.arbutusbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arbutus Biopharma Corp

Pennsylvania Biotech Center's economic impact grows to $7B as it expands in Bucks County, report finds - May 20th, 2022 7:04 pm
Arbutus to Present at H.C. Wainwright Global Investment Conference - May 17th, 2022 11:30 am
Moderna Files Motion To Dismiss COVID-19 Vaccine Related Patent Claims: WSJ - May 9th, 2022 12:16 pm
Party Time: Brokers Just Made Major Increases To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Earnings Forecasts - May 7th, 2022 12:05 pm
Arbutus Biopharma (ABUS) Q1 2022 Earnings Call Transcript - May 5th, 2022 6:30 pm
Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates - May 5th, 2022 12:55 pm
Arbutus Reports First Quarter 2022 Financial Results and Provides Corporate Update - May 5th, 2022 11:30 am
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Lags Revenue Estimates - May 4th, 2022 10:55 pm
Arbutus Biopharma (NASDAQ:ABUS) investors are sitting on a loss of 33% if they invested a year ago - May 2nd, 2022 11:58 am
Arbutus to Report First Quarter 2022 Financial Results and Provide Corporate Update - Apr 21st, 2022 11:30 am
Pfizer's Canadian partner sues Arbutus Biopharma in Covid-19 vaccine patent dispute - Mar 24th, 2022 6:51 pm
UPDATE 1-Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccine - Mar 18th, 2022 5:00 pm
Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccine - Mar 18th, 2022 3:04 pm
This 1 New Threat Could Punish Moderna Stock - Mar 9th, 2022 1:00 pm
New Forecasts: Here's What Analysts Think The Future Holds For Arbutus Biopharma Corporation (NASDAQ:ABUS) - Mar 8th, 2022 9:13 am
What Type Of Shareholders Own The Most Number of Arbutus Biopharma Corporation (NASDAQ:ABUS) Shares? - Mar 5th, 2022 11:48 am
Arbutus Biopharma (ABUS) Q4 2021 Earnings Call Transcript - Mar 3rd, 2022 10:30 pm
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates - Mar 3rd, 2022 3:05 pm
Arbutus Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update - Mar 3rd, 2022 12:30 pm
Bucks County biopharm firm files lawsuit against Moderna over Covid-19 vaccine - Feb 28th, 2022 4:22 pm